-
1
JAK inhibitors: a new choice for diabetes mellitus?
Published 2025-01-01Subjects: “…JAK inhibitors…”
Get full text
Article -
2
Baricitinib represses the myocardial fibrosis via blocking JAK/STAT and TGF-β1 pathways in vivo and in vitro
Published 2025-01-01Subjects: Get full text
Article -
3
Tofacitinib and budesonide treatment affect stemness and chemokine release in IBD patient-derived colonoids
Published 2025-01-01Subjects: Get full text
Article -
4
Response to upadacitinib monotherapy in a patient with eczematid-like pigmented purpuric dermatosis
Published 2025-02-01Subjects: “…JAK inhibitor…”
Get full text
Article -
5
Impact in Clinical Practice of the European Medicines Agency Health Alert About the Restriction of the Use of JAK Inhibitors
Published 2024-12-01Subjects: “…JAK inhibitors…”
Get full text
Article -
6
Monocyte STAT1 phosphorylation and treatment response of JAK inhibitors in chronic nonbacterial osteomyelitis
Published 2025-01-01Subjects: Get full text
Article -
7
Biomimetic polydopamine loaded with janus kinase inhibitor for synergistic vitiligo therapy via hydrogel microneedles
Published 2025-01-01Subjects: Get full text
Article -
8
A Threefold Association Between Vitiligo and Alopecia Areata: Results from a Nationwide Case-control Observational Study
Published 2025-02-01Subjects: Get full text
Article -
9
Mechanism of triptolide regulating proliferation and apoptosis of hepatoma cells by inhibiting JAK/STAT pathway
Published 2025-01-01Subjects: Get full text
Article -
10
Osimertinib exacerbates immune checkpoint inhibitor-related severe adverse events by activating the IL-6/JAK/STAT3 pathway in macrophages
Published 2024-12-01Subjects: Get full text
Article -
11
Vitamin A family suppresses periodontitis by restoring mitochondrial metabolic reprogramming in macrophages through JAK-STAT pathway
Published 2025-01-01Subjects: Get full text
Article -
12
Bullous pemphigoid treated with baricitinib as steroid-sparing therapy for a patient with uncontrolled diabetes
Published 2025-03-01Subjects: Get full text
Article -
13
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future?
Published 2025-01-01Subjects: “…JAK inhibitors…”
Get full text
Article -
14
Successful Achievement of Demanding Outcomes in Upadacitinib-Treated Atopic Dermatitis Patients: A Real-World, 96-Week Single-Centre Study
Published 2025-01-01Subjects: Get full text
Article -
15
CEACAM5 exacerbates asthma by inducing ferroptosis and autophagy in airway epithelial cells through the JAK/STAT6-dependent pathway
Published 2025-12-01Subjects: Get full text
Article -
16
Suberosin attenuates rheumatoid arthritis by repolarizing macrophages and inhibiting synovitis via the JAK/STAT signaling pathway
Published 2025-01-01Subjects: Get full text
Article -
17
Folate alleviated skin inflammation and fibrosis resulting from impaired homocysteine metabolism
Published 2025-03-01Subjects: Get full text
Article -
18
Case report: JAK inhibitor treatment of immune dysregulation symptoms in a patient with PTPN2 deficiency
Published 2025-01-01Subjects: Get full text
Article -
19
Selective JAK2 pathway inhibition enhances anti-leukemic functionality in CD19 CAR-T cells
Published 2025-02-01Subjects: Get full text
Article -
20
Unveiling prognostic value of JAK/STAT signaling pathway related genes in colorectal cancer: a study of Mendelian randomization analysis
Published 2025-02-01Subjects: Get full text
Article